News
Articles
We actively participated in the "veptc 2024" course in Palermo, Sicily
Colleagues from GHC Genetics laboratory actively participated in the important "Variant effect prediction training course", which took place on 13-16.10.2024 in Palermo, Sicily. The event was organized by the Human Genome Organization (HUGO) and focused on predicting the effects of genomic variants found in patients using sequencing. This course focuses on helping participants to effectively analyse and interpret DNA variants, a crucial task for those involved in genomic diagnostics, such as molecular geneticists, clinical geneticists and laboratory professionals.
Article by Dr. Tereza Piskáčková on genetic predisposition to prostate cancer
Tereza Piskáčková, M.D., published an article "Hereditary predisposition for prostate cancer" in the latest issue of the periodical Acta Medicinae. The full article can be downloaded in the appendix of this article.
We have launched a unique programme "STROM PREVENCE" at the Prosek Polyclinic
On 12 September, we launched a unique preventive programme called STROM PREVENCE at the Prosek Polyclinic. It will offer clients important preventive genetic tests for predisposition to breast, ovarian and prostate cancer, increased blood clotting, celiac disease and others. As part of the launch, our unique three-metre high statue of Venus, a symbol of breast cancer prevention, was unveiled at the clinic.
Single blood test predicts 30-year cardiovascular disease risks for women
Research supported by the National Institutes of Health (NIH) has found that measuring two types of fat in the bloodstream along with C-reactive protein (CRP), a marker of inflammation, can predict a woman’s risk for cardiovascular disease decades later. These findings, presented as late-breaking research at the European Society of Cardiology Congress 2024, were published in the New England Journal of Medicine.